Literature DB >> 15857684

Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure.

Sumita Chakrabarti1, Annette Regec, Alan R Gintzler.   

Abstract

Biochemical data indicate mu-opioid receptor (MOR) coupling predominantly to the G(i) and G(o) family. Additionally, MOR coupling to G(s) is suggested by pharmacological assessments that have revealed excitatory MOR effects, which are resistant to pertussis toxin and sensitive to cholera toxin. However, biochemical evidence for such interactions remains elusive; G(salpha) has not been shown to be present in immunoprecipitate obtained using anti-MOR antibodies. In the current study, the presence of MOR in immunoprecipitate obtained with anti-G(salpha ) antibodies was investigated using Chinese hamster ovary cells stably transfected with MOR (MOR-CHO). MOR Western analyses of opioid naive MOR-CHO membranes immunoprecipitated using anti-G(salpha) antibodies reveal the presence of an approximately 75-80 kDa MOR species. Interestingly, acute and chronic morphine treatment markedly enhances the magnitude of MOR that co-immunoprecipitates with G(salpha), despite the concomitant down-regulation of membrane MOR protein. Enhanced co-precipitation of MOR with G(salpha) occurs without a concomitant increase in the immunoprecipitated G(salpha) protein indicating their increased association. In contrast, chronic morphine diminishes the co-immunoprecipitation of MOR with G(ialpha). Moreover, although only a single MOR species co-immunoprecipitated with G(salpha), MOR Western analysis of MOR-CHO membranes as well as immunoprecipitate obtained with either anti-MOR or anti-G(ialpha) antibodies reveals the presence of multiple molecular mass species of MOR. These data reveal the existence of a subset of MORs whose association with G(salpha) can be enhanced by morphine exposure. Notably, the regulation by chronic morphine of MOR association with G(salpha) and G(ialpha) is reciprocal. The relevance of MOR-Gs(alpha) coupling to opioid tolerance formation is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857684     DOI: 10.1016/j.molbrainres.2004.12.016

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  24 in total

Review 1.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

2.  Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; James E Zadina; Tarak Sharma; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2011-10-04       Impact factor: 4.030

3.  Shared mechanisms for opioid tolerance and a transition to chronic pain.

Authors:  Elizabeth K Joseph; David B Reichling; Jon D Levine
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

Review 4.  Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

Authors:  C Hawkes; A Amritraj; R G Macdonald; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

5.  Contribution of adrenomedullin to the switch of G protein-coupled μ-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats.

Authors:  Dongmei Wang; Juan Zeng; Qi Li; Jianzhong Huang; Réjean Couture; Yanguo Hong
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

6.  Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.

Authors:  David Andrew Tompkins; Ryan K Lanier; Joseph A Harrison; Eric C Strain; George E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

7.  Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neurochem       Date:  2019-10-20       Impact factor: 5.372

8.  Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors.

Authors:  Eunhae Kim; Amy L Clark; Alexi Kiss; Jason W Hahn; Robin Wesselschmidt; Carmine J Coscia; Mariana M Belcheva
Journal:  J Biol Chem       Date:  2006-09-01       Impact factor: 5.157

9.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

10.  Subcellular localization of mu-opioid receptor G(s) signaling.

Authors:  Sumita Chakrabarti; Andrew Chang; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2010-01-22       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.